ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Detheux Michel
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Feltquate David
ITeos Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Feltquate David
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Van Hauwermeiren Timothy
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Tony W
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee David K
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Davis Aaron I.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hallal David
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSimone Jill
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RHOADS ANN D
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Iannone Robert
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities- Boxer Capital, LLC
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities- RA CAPITAL MANAGEMENT, L.P.
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Boxer Capital, LLC(8.1%),Boxer Asset Management Inc.(8.1%), etc.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gall Matthew
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Call Matthew
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McGrath Yvonne
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Detheux Michel
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSimone Jill
No Data
No Data